Astrocytoma, IDH-Mutant, Grade 4 — Trials

Astrocytoma, IDH-Mutant, Grade 4 — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 8%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–16 of 16 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07831369	VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma	recruiting	Phase 2	52	Inova Health Care ServicesOTHER	1	Sep 21, 2026	clinicaltrials
NCT06860594	Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma	recruiting	Phase 1	30	National Cancer Institute (NCI)NIH	1	Sep 2, 2026	clinicaltrials